The Fungal Secretory Peptide Micasin Induces Itch by Activating MRGPRX1/C11/A1 on Peripheral Neurons

Haifeng Yang1, Yian Chen2, Luyao Wang2

  • 1National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan, China; State Key Laboratory of Virology, Shenzhen Research Institute, College of Life Sciences, Wuhan University, Wuhan, China.

Insights

A fungal peptide called micasin from Microsporium canis causes itch by activating specific neurons. This discovery offers new therapeutic targets for fungal infection-related itching.

Area of Science:

  • Dermatology
  • Neuroscience
  • Molecular Biology

Background:

  • Pruritus (itching) is a primary symptom of dermatophytosis, a fungal infection.
  • Microsporium canis is a common cause of dermatophytosis, but the itch-inducing agents and mechanisms are unclear.

Purpose of the Study:

  • To identify the specific agents secreted by Microsporium canis that cause pruritus.
  • To elucidate the molecular mechanisms underlying M. canis-induced itch.

Main Methods:

  • Mice were used to test the itch-inducing effects of M. canis secretions.
  • The fungal peptide micasin was identified and its role in activating neurons was investigated.
  • Knockout and antagonistic experiments were performed on specific receptors (MRGPRX1/C11/A1 and MRGPRX2/b2).
  • Structural analysis of MRGPRX1 was conducted using chimeras and variants.

Main Results:

  • M. canis secretions dose-dependently induced itch in mice.
  • The peptide micasin was identified as a key pruritogenic agent, activating dorsal root ganglia neurons.
  • Micasin-triggered itch involved the activation of MRGPRX1/C11/A1, not MRGPRX2/b2.
  • Specific domains and residues of MRGPRX1 were found crucial for micasin activation.

Conclusions:

  • Micasin is a novel pruritogenic peptide from M. canis that activates nonhistaminergic itch pathways.
  • MRGPRX1 is the primary receptor mediating micasin-induced pruritus.
  • This research identifies potential therapeutic targets for treating fungal infection-related itching.